TL1A exerts pleiotropic effects on cell proliferation, activation, and differentiation of immune cells, which involves autoimmune diseases such as IBD, RA, and ankylosing spondylitis (AS). This evidence concerns the gene TNFSF15 and ankylosing spondylitis.